Pacific Biosciences of California, Inc. (PACB) Stock Overview
Explore Pacific Biosciences of California, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Pacific Biosciences of California, Inc. (PACB)
Key Financials
Key Financials
Market Cap
357.2M
P/E Ratio
-2.68
EPS (TTM)
$-0.41
ROE
-49.62%
PACB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Pacific Biosciences of California, Inc. (NASDAQ: PACB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pacific Biosciences of California, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PACB on the NASDAQ shows an RSI of 35.21, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.83 for the NASDAQ listing.
Key metrics behind Pacific Biosciences of California, Inc.'s NASDAQ-traded stock include a P/E ratio of -2.68 and a market capitalization of 357.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PACB on the NASDAQ.